Antifungal preparations in solution in gamma-butyrolactone, useful for the topical treatment of onychomycosis, whose therapeutic effect may be reinforced by the keratolytic action of the salicylic acid and the preparations may advantageously be made viscous, gelled or filmogenic, with or without a colorant.